# A Study of JNJ-73763989 in Healthy Japanese Adult Participants

> **NCT04002752** · PHASE1 · COMPLETED · sponsor: **Janssen Sciences Ireland UC** · enrollment: 25 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-73763989
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04002752
- **Lead sponsor:** Janssen Sciences Ireland UC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-04
- **Primary completion:** 2019-08-23
- **Final completion:** 2019-08-23
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04002752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04002752, "A Study of JNJ-73763989 in Healthy Japanese Adult Participants". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04002752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*